Cardiac [99mTc]Tc-hydroxydiphosphonate uptake on bone scintigraphy in patients with hereditary transthyretin amyloidosis: an early follow-up marker?

被引：0
作者：
H. S. A. Tingen
A. Tubben
J. Bijzet
M. P. van den Berg
P. van der Meer
E. J. Houwerzijl
F. L. H. Muntinghe
P. A. van der Zwaag
A. W. J. M. Glaudemans
M. I. F. J. Oerlemans
C. Knackstedt
M. Michels
A. Hirsch
B. P. C. Hazenberg
R. H. J. A. Slart
H. L. A. Nienhuis
机构：
[1] University Medical Centre Groningen and Amyloidosis Centre of Expertise,Department of Nuclear Medicine and Molecular Imaging
[2] University Medical Centre Groningen and Amyloidosis Centre of Expertise,Department of Cardiology
[3] University Medical Centre Groningen and Amyloidosis Centre of Expertise,Department of Rheumatology & Clinical Immunology
[4] University Medical Centre Groningen and Amyloidosis Centre of Expertise,Department of Internal Medicine
[5] University Medical Centre Groningen and Amyloidosis Centre of Expertise,Department of Clinical Genetics
[6] University Medical Centre Utrecht,Department of Cardiology and Member of the European Reference Network for rare, low prevalence and complex diseases of the heart: ERN GUARD
[7] Cardiovascular Research Institute Maastricht (CARIM),Heart
[8] Maastricht University Medical Centre +,Department of Cardiology
[9] University Medical Centre Rotterdam,Department of Cardiology
[10] University Medical Centre Rotterdam,Department of Radiology and Nuclear Medicine
[11] University of Twente,Biomedical Photonic Imaging Group, Faculty of Science and Technology
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2024年 / 51卷
关键词：
ATTR-CM; ATTRv amyloidosis; Bone scintigraphy; Gene silencing; TTR stabilizers; Monitoring;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：681 / 690
页数：9
相关论文
共 140 条
  • [21] Damy T(2022)Varying levels of small microcalcifications and macrophages in ATTR and AL cardiac amyloidosis: implications for utilizing nuclear medicine studies to subtype amyloidosis Int J Cardiol 352 84-1016
  • [22] Dispenzieri A(2018)Cardiac microcalcifications in transthyretin (ATTR) amyloidosis N Engl J Med 379 1007-65
  • [23] Damy T(2019)Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy Amyloid 26 55-210
  • [24] Garcia-Pavia P(2018)Treatment of hereditary and acquired forms of transthyretin amyloidosis in the era of personalized medicine: the role of randomized controlled trials Amyloid 25 203-905
  • [25] Hanna M(2021)Quantitation of Eur J Heart Fail 23 895-625
  • [26] Judge DP(2020) Tc-DPD uptake in patients with transthyretin-related cardiac amyloidosis J Cardiol 76 618-undefined
  • [27] Merlini G(undefined)Expert consensus on the monitoring of transthyretin amyloid cardiomyopathy undefined undefined undefined-undefined
  • [28] Gundapaneni B(undefined)Diagnostic performance of PET for detection of cardiac amyloidosis: a systematic review and meta-analysis undefined undefined undefined-undefined
  • [29] Lohrmann G(undefined)undefined undefined undefined undefined-undefined
  • [30] Pipilas A(undefined)undefined undefined undefined undefined-undefined
12345678910